0000711404-24-000062 | 10-Q | XBRL Viewer

Print Document

Acquisitions and Joint Venture (Details) $ in Millions				1 Months Ended
Acquisitions and Joint Venture (Details) $ in Millions	Aug. 01, 2024 USD ($)	Jun. 07, 2024 USD ($)	Nov. 01, 2023 USD ($) installment	Mar. 31, 2022 USD ($)	Jul. 31, 2024 USD ($)	Oct. 31, 2023 USD ($)	Feb. 28, 2022
Business Acquisition [Line Items]
Goodwill					$ 3,777.2	$ 3,624.5
Proceeds from sale of interest in a subsidiary				$ 52.1
Payments to form joint venture				10.0
Essilor International SAS
Business Acquisition [Line Items]
Payments to form joint venture				$ 10.0
SightGlass Vision, Inc.
Business Acquisition [Line Items]
Equity method investment, ownership percentage				50.00%			100.00%
Cook Medical
Business Acquisition [Line Items]
Aggregate consideration			$ 300.0
Payments to acquire business			$ 200.0
Number of installments \| installment			2
Present value of acquisition purchase price			$ 291.6
Goodwill			107.2
Cook Medical \| Technology
Business Acquisition [Line Items]
Finite-lived intangibles			157.9
Cook Medical \| Customer relationships
Business Acquisition [Line Items]
Finite-lived intangibles			26.6
Cook Medical \| Payables First Installment
Business Acquisition [Line Items]
Payables incurred in acquisition			50.0
Cook Medical \| Payables Second Installment
Business Acquisition [Line Items]
Payables incurred in acquisition			$ 50.0
U.S.-based medical device company \| Subsequent Event
Business Acquisition [Line Items]
Aggregate consideration	$ 100.0
Fertility company
Business Acquisition [Line Items]
Purchase price of acquisition		$ 33.5
Deferred tax liability		8.3
Fertility company \| Composite intangible assets
Business Acquisition [Line Items]
Intangible assets acquired		$ 39.6

Contingencies and Commitments	9 Months Ended
Contingencies and Commitments	Jul. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Contingencies and Commitments	Note 10. Contingencies and Commitments The Company is involved in various lawsuits, claims and other legal matters from time to time that arise in the ordinary course of conducting business, including matters involving our products, intellectual property, supplier relationships, distributors, competitor relationships, employees and other matters. The Company does not believe that the ultimate resolution of these proceedings or claims pending against it could have a material adverse effect on its financial condition or results of operations. At each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450, Contingencies. Legal fees are expensed as incurred. As of July 31, 2024, the Company entered into additional leases that have not yet commenced in order to expand capacity. The undiscounted lease payments are estimated at $214.0 million for leases that will commence between the fourth quarter of fiscal 2024 through fiscal 2026, with initial terms ranging from 15 to 25 years.

- Definition

The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 720
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483359/720-20-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 5.Y.Q4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480102/450-20-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 5.Y.Q2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480102/450-20-S99-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/450-20/tableOfContent

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-4

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-9

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 30
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/450-30/tableOfContent

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483049/450-30-50-1

+ Details

Stockholders' Equity - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023	Mar. 31, 2017
Stockholders' Equity Note [Abstract]
Share repurchase program, authorized amount for repurchase					$ 1,000.0
Share repurchase program, remaining authorized amount for repurchase	$ 256.4		$ 256.4
Number of shares (in shares)	0	0	0	0
Dividends on common stock			$ 0.0	$ 1.5

Consolidated Condensed Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Jul. 31, 2024	Jul. 31, 2023
Cash flows from operating activities:
Net income	$ 274.8	$ 209.7
Depreciation and amortization	284.1	275.0
Change in fair value of contingent consideration	0.0	(31.8)
Accrual for acquisition termination fee	0.0	45.0
Net changes in operating capital	(302.5)	(188.8)
Other non-cash items	184.8	124.2
Net cash provided by operating activities	441.2	433.3
Cash flows from investing activities:
Purchases of property, plant and equipment	(281.2)	(247.5)
Acquisitions of businesses and assets, net of cash acquired, and other	(241.8)	(40.7)
Net cash used in investing activities	(523.0)	(288.2)
Cash flows from financing activities:
Proceeds from long-term debt, net of issuance costs	2,807.8	1,652.0
Repayments of long-term debt	(2,749.2)	(1,490.4)
Net repayments of short-term debt	(3.4)	(335.5)
Net proceeds related to share-based compensation awards	6.5	2.2
Dividends on common stock	0.0	(1.5)
Issuance of common stock for employee stock purchase plan	5.9	5.8
Net cash provided by (used in) financing activities	67.6	(167.4)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	3.1	1.2
Net decrease in cash, cash equivalents, and restricted cash	(11.1)	(21.1)
Cash, cash equivalents, and restricted cash at beginning of period	120.9	138.6
Cash, cash equivalents, and restricted cash at end of period	109.8	117.5
Reconciliation of cash flow information:
Cash and cash equivalents	109.7	117.3
Restricted cash included in other current assets	0.1	0.2
Total cash, cash equivalents, and restricted cash	$ 109.8	$ 117.5

General (Details)
$ / shares in Units, $ in Millions

3 Months Ended

9 Months Ended

Feb. 16, 2024

$ / shares

Jul. 31, 2024

USD ($)

$ / shares

Jul. 31, 2023

USD ($)

Jul. 31, 2024

USD ($)

$ / shares

Jul. 31, 2023

USD ($)

Oct. 31, 2023

$ / shares

^[1]

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Stock split, conversion ratio

Common stock, par value (in dollars per share) | $ / shares

$ 0.10

^[1]

$ 0.10

^[1]

$ 0.10

Revenue recognized | $

$ 30.0

$ 92.0

$ 80.0

[1]	All periods presented have been adjusted to reflect the four-for-one stock split effected on February 16, 2024. Refer to Note 1. General for further information.

Business Segment Information - Schedule of Identifiable Assets by Segment (Details) - USD ($) $ in Millions	Jul. 31, 2024	Oct. 31, 2023
Segment Reporting Information [Line Items]
Total Identifiable assets	$ 12,108.0	$ 11,658.9
Operating Segments \| CooperVision
Segment Reporting Information [Line Items]
Total Identifiable assets	7,172.0	7,044.0
Operating Segments \| CooperSurgical
Segment Reporting Information [Line Items]
Total Identifiable assets	4,716.8	4,351.8
Corporate
Segment Reporting Information [Line Items]
Total Identifiable assets	$ 219.2	$ 263.1

- Definition

Amount of asset recognized for present right to economic benefit.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 48
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-48

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 49
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-49

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 810
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (bb)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481203/810-10-50-3

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 810
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 25
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481231/810-10-45-25

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481687/323-10-50-3

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-28

Reference 12: http://www.xbrl.org/2003/role/exampleRef
-Topic 852
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481372/852-10-55-10

Reference 13: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479168/946-830-55-12

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(8))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(18))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 852
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481404/852-10-50-7

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

+ Details

Inventories (Tables)

9 Months Ended

Jul. 31, 2024

Inventory Disclosure [Abstract]

Schedule of inventories


(In millions)	July 31, 2024		October 31, 2023
Raw materials	$	214.6	$	207.3
Work-in-process	19.5		19.0
Finished goods	545.2		509.3
Total inventories	$	779.3	$	735.6

Intangible Assets (Tables)

9 Months Ended

Jul. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of finite-lived intangible assets

Intangible assets consisted of the following:


	July 31, 2024				October 31, 2023
(In millions)	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization		Weighted-Average Amortization Period (in years)

Intangible assets with definite lives:
Customer relationships	$	1,123.0	$	387.6	$	1,099.2	$	345.8	19
Composite intangible assets (1)	1,101.5		477.9		1,061.9		424.8		15
Technology	660.0		372.7		494.5		335.4		12
Trademarks	204.2		87.1		208.9		81.1		15
License and distribution rights and other	48.0		26.5		51.6		28.0		11
	3,136.7		$	1,351.8	2,916.1		$	1,215.1	16
Less: accumulated amortization and translation	1,351.8				1,215.1
Intangible assets with definite lives, net	1,784.9				1,701.0
Intangible assets with indefinite lives, net (2)	1.9				9.3
Total other intangibles, net	$	1,786.8			$	1,710.3

(1) Composite intangible assets primarily consist of technology, trade name, New Drug Application approval and physician relationships. The components are not reflected separately or within the corresponding categories because they are inextricably linked.

(2) Intangible assets with indefinite lives include technology and trademarks.

Schedule of indefinite-lived intangible assets

Intangible assets consisted of the following:


	July 31, 2024				October 31, 2023
(In millions)	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization		Weighted-Average Amortization Period (in years)

Intangible assets with definite lives:
Customer relationships	$	1,123.0	$	387.6	$	1,099.2	$	345.8	19
Composite intangible assets (1)	1,101.5		477.9		1,061.9		424.8		15
Technology	660.0		372.7		494.5		335.4		12
Trademarks	204.2		87.1		208.9		81.1		15
License and distribution rights and other	48.0		26.5		51.6		28.0		11
	3,136.7		$	1,351.8	2,916.1		$	1,215.1	16
Less: accumulated amortization and translation	1,351.8				1,215.1
Intangible assets with definite lives, net	1,784.9				1,701.0
Intangible assets with indefinite lives, net (2)	1.9				9.3
Total other intangibles, net	$	1,786.8			$	1,710.3

(2) Intangible assets with indefinite lives include technology and trademarks.

Schedule of remaining amortization expenses for intangible assets with definite lives

As of July 31, 2024, the estimate of future amortization expenses for intangible assets with definite lives is as follows:


Fiscal Years:	(In millions)
Remainder of 2024	$	48.6
2025	191.6
2026	184.0
2027	169.7
2028	165.2
Thereafter	1,025.8
Total remaining amortization for intangible assets with definite lives	$	1,784.9

Intangible Assets - Narrative (Details)	9 Months Ended
Intangible Assets - Narrative (Details)	Jul. 31, 2024 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Impairment of goodwill and intangible assets	$ 0

Earnings Per Share - Schedule of Stock Options and Restricted Stock Units that were not Included in the Diluted Earnings Per Share Calculation (Details) - $ / shares shares in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Exercise prices, lower limit (in dollars per share)	$ 82.46	$ 82.46	$ 82.46	$ 75.03
Exercise prices, upper limit (in dollars per share)	$ 101.54	$ 101.54	$ 101.54	$ 101.54
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Number of awards excluded (in shares)	828	820	828	1,244
Restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Number of awards excluded (in shares)	5	8	2,000	64

Consolidated Condensed Statements of Stockholders' Equity (Parenthetical)	3 Months Ended
	Jul. 31, 2023 $ / shares	Jan. 31, 2023 $ / shares
Statement of Stockholders' Equity [Abstract]
Dividends on common stock (in dollars per share)	$ 0.01	$ 0.01

Business Segment Information (Tables)

9 Months Ended

Jul. 31, 2024

Segment Reporting [Abstract]

Schedule of segment information

Segment information:


Periods Ended July 31,	Three Months				Nine Months
(In millions)	2024		2023		2024		2023
CooperVision net sales by category:
Toric and multifocal	$	326.4	$	296.5	$	934.0	$	838.5
Sphere, other	349.2		333.7		999.0		962.3


Total CooperVision net sales	$	675.6	$	630.2	$	1,933.0	$	1,800.8
CooperSurgical net sales by category:
Office and surgical	$	197.9	$	178.4	$	571.9	$	506.6
Fertility	129.3		121.6		372.1		358.7
Total CooperSurgical net sales	327.2		300.0		944.0		865.3
Total net sales	$	1,002.8	$	930.2	$	2,877.0	$	2,666.1
Operating income (loss):
CooperVision	$	172.7	$	151.7	$	487.7	$	449.7
CooperSurgical	41.3		18.8		86.9		0.3
Corporate	(21.5)		(18.9)		(67.3)		(52.6)
Total operating income	192.5		151.6		507.3		397.4
Interest expense	28.5		26.8		87.3		79.0


Other expense, net	0.3		6.0		6.3		11.9
Income before income taxes	$	163.7	$	118.8	$	413.7	$	306.5

Schedule of identifiable assets by segment


(In millions)	July 31, 2024		October 31, 2023
Total identifiable assets:
CooperVision	$	7,172.0	$	7,044.0
CooperSurgical	4,716.8		4,351.8
Corporate	219.2		263.1
Total	$	12,108.0	$	11,658.9

Schedule of net sales to unaffiliated customers by country of domicile

Geographic information:


Periods Ended July 31,	Three Months				Nine Months
(In millions)	2024		2023		2024		2023
Net sales to unaffiliated customers by country of domicile:
United States	$	511.2	$	462.5	$	1,460.6	$	1,340.4
Europe	297.0		279.7		850.3		777.4
Rest of world	194.6		188.0		566.1		548.3
Total	$	1,002.8	$	930.2	$	2,877.0	$	2,666.1

Schedule of net property, plant and equipment by country of domicile


(In millions)	July 31, 2024		October 31, 2023
Net property, plant and equipment by country of domicile:
United States	$	1,094.1	$	1,027.6
Europe	377.9		325.9
Rest of world	275.6		279.1
Total	$	1,747.6	$	1,632.6

Contingencies and Commitments (Details) $ in Millions	Jul. 31, 2024 USD ($)
Operating leases not yet commenced
Lessee, Lease, Description [Line Items]
Undiscounted lease payments	$ 214.0
Minimum
Lessee, Lease, Description [Line Items]
Lease term (in years)	15 years
Maximum
Lessee, Lease, Description [Line Items]
Lease term (in years)	25 years

Financing Arrangements - Narrative (Details) - Line of Credit - USD ($) $ in Millions	May 01, 2024	Jul. 31, 2024	Dec. 17, 2021	Apr. 01, 2020
2024 Credit Agreement
Schedule of Long Term And Short Term Debt Instruments [Line Items]
Potential additional borrowing capacity	$ 1,150.0
Potential additional borrowing capacity, percentage of EBITDA	100.00%
2024 Credit Agreement \| Base rate \| Minimum
Schedule of Long Term And Short Term Debt Instruments [Line Items]
Basis spread on variable rate	0.00%
2024 Credit Agreement \| Base rate \| Maximum
Schedule of Long Term And Short Term Debt Instruments [Line Items]
Basis spread on variable rate	0.50%
2024 Credit Agreement \| Adjusted SOFR \| Minimum
Schedule of Long Term And Short Term Debt Instruments [Line Items]
Basis spread on variable rate	0.87%
2024 Credit Agreement \| Adjusted SOFR \| Maximum
Schedule of Long Term And Short Term Debt Instruments [Line Items]
Basis spread on variable rate	1.50%
2024 Credit Agreement \| Adjusted foreign currency rate \| Minimum
Schedule of Long Term And Short Term Debt Instruments [Line Items]
Basis spread on variable rate	0.87%
2024 Credit Agreement \| Adjusted foreign currency rate \| Maximum
Schedule of Long Term And Short Term Debt Instruments [Line Items]
Basis spread on variable rate	1.50%
2021 Term Loan Facility
Schedule of Long Term And Short Term Debt Instruments [Line Items]
Aggregate principal amount			$ 1,500.0
Amount outstanding		$ 1,500.0
Interest rate		6.44%
Revolving Credit Facility \| 2024 Credit Agreement
Schedule of Long Term And Short Term Debt Instruments [Line Items]
Aggregate principal amount	$ 2,300.0
Amount outstanding		$ 1,100.0
Interest rate		6.57%
Revolving Credit Facility \| 2024 Credit Agreement \| Minimum
Schedule of Long Term And Short Term Debt Instruments [Line Items]
Commitment fee percentage	0.10%
Revolving Credit Facility \| 2024 Credit Agreement \| Maximum
Schedule of Long Term And Short Term Debt Instruments [Line Items]
Commitment fee percentage	0.20%
Revolving Credit Facility \| 2020 Credit Agreement
Schedule of Long Term And Short Term Debt Instruments [Line Items]
Aggregate principal amount				$ 1,290.0
Revolving Credit Facility And Term Loan Facility 2020 \| 2020 Credit Agreement
Schedule of Long Term And Short Term Debt Instruments [Line Items]
Potential additional borrowing capacity				1,605.0
Term Loan Facility 2020 \| 2020 Credit Agreement
Schedule of Long Term And Short Term Debt Instruments [Line Items]
Aggregate principal amount				$ 850.0
Repayment of borrowings	$ 1,170.0

Cover - shares	9 Months Ended
Cover - shares	Jul. 31, 2024	Aug. 23, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jul. 31, 2024
Document Transition Report	false
Entity File Number	1-8597
Entity Registrant Name	The Cooper Companies, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	94-2657368
Entity Address, Address Line One	6101 Bollinger Canyon Road
Entity Address, Address Line Two	Suite 500
Entity Address, City or Town	San Ramon
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94583
City Area Code	925
Local Phone Number	460-3600
Title of 12(b) Security	Common Stock, $0.10 par value
Trading Symbol	COO
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		199,155,603
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Entity Central Index Key	0000711404
Current Fiscal Year End Date	--10-31

Consolidated Condensed Balance Sheets - USD ($)
$ in Millions

Jul. 31, 2024

Oct. 31, 2023

Current assets:

Cash and cash equivalents

$ 109.7

$ 120.8

Trade accounts receivable, net of allowance for credit losses of $42.8 at July 31, 2024, and $31.3 at October 31, 2023

739.0

609.7

Inventories (Note 3)

779.3

735.6

Prepaid expense and other current assets

298.7

238.8

Total current assets

1,926.7

1,704.9

Property, plant and equipment, net

1,747.6

1,632.6

Goodwill

3,777.2

3,624.5

Other intangibles, net (Note 4)

1,786.8

1,710.3

Deferred tax assets

2,248.3

2,349.5

Other assets

621.4

637.1

Total assets

12,108.0

11,658.9

Current liabilities:

Short-term debt (Note 5)

40.8

45.4

Accounts payable

222.0

261.9

Employee compensation and benefits

156.5

174.8

Deferred revenue

126.4

123.6

Other current liabilities

423.8

363.3

Total current liabilities

969.5

969.0

Long-term debt (Note 5)

2,591.6

2,523.8

Deferred tax liabilities

94.9

101.5

Long-term tax payable

59.0

90.2

Deferred revenue

190.8

184.2

Other liabilities

277.0

239.2

Total liabilities

4,182.8

4,107.9

Contingencies (Note 10)

Stockholders’ equity:

Preferred stock, $0.10 par value, 1.0 shares authorized, zero shares issued or outstanding

^[1]

0.0

Common stock, $0.10 par value, 480.0 shares authorized, 216.7 issued and 199.1 outstanding at July 31, 2024, and 215.8 issued and 198.1 outstanding at October 31, 2023

^[1]

21.7

21.6

Additional paid-in capital

^[1]

1,884.7

1,817.2

Accumulated other comprehensive loss

^[1]

(425.1)

(453.8)

Retained earnings

^[1]

7,150.9

6,876.1

Treasury stock at cost: 17.6 shares at July 31, 2024, and 17.7 shares at October 31, 2023

^[1]

(707.2)

(710.3)

Total Cooper stockholders’ equity

^[1]

7,925.0

7,550.8

Noncontrolling interests

^[1]

0.2

Stockholders’ equity (Note 9)

^[1]

7,925.2

7,551.0

Total liabilities and stockholders’ equity

$ 12,108.0

$ 11,658.9

[1]	All periods presented have been adjusted to reflect the four-for-one stock split effected on February 16, 2024. Refer to Note 1. General for further information.

Acquisitions and Joint Venture	9 Months Ended
Acquisitions and Joint Venture	Jul. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Acquisitions and Joint Venture	Note 2. Acquisitions and Joint Venture All acquisitions were funded by cash generated from operations or facility borrowings. On June 7, 2024, CooperSurgical acquired a fertility company that specializes in sperm separation devices. The purchase price of the acquisition was $33.5 million. The Company accounted for this acquisition as an asset acquisition, whereby the Company allocated the total cost of the acquisition to the net assets acquired on the basis of their estimated relative fair values on the acquisition date. The primary asset acquired in this asset acquisition is a composite intangible asset of $39.6 million. The value of the composite intangible asset reflects, in addition to the purchase price, a deferred tax liability of $8.3 million arising from book/tax basis differences generated upon the acquisition. The composite intangible asset encompasses the portfolio of intellectual property associated with the sperm separation devices including the patents, trademarks, customer relationships, regulatory approvals, and commercialization rights, which have been valued as a single composite intangible asset as they are inextricably linked. On November 1, 2023, CooperSurgical completed the acquisition of select Cook Medical assets focused primarily on the obstetrics, doppler monitoring, and gynecology surgery markets. The purchase price of the acquisition was $300.0 million, with $200.0 million paid at closing and two cash payments of $50.0 million each to be paid on November 1, 2024, and November 1, 2025. The present value of the acquisition purchase price was $291.6 million, which is included in the Company's balance sheet. Assets acquired primarily comprised of $157.9 million of technologies, $26.6 million of customer relationship related intangibles, and $107.2 million of goodwill. The goodwill is deductible for tax purposes. Joint Venture CooperVision and Essilor International SAS (Essilor) executed a Contribution Agreement and a Stock Purchase Agreement (the Agreements) in March 2022 to form a joint venture in SightGlass Vision, Inc. (SGV), which is a medical device company developing spectacle lenses for myopia management. Essilor paid CooperVision $52.1 million in exchange for a 50% interest in SGV and their proportionate share of the revenue payments. As part of the Agreements, each party contributed their interest in SGV and $10 million in cash. Prior to March 2022, CooperVision owned 100% of SGV. Further information regarding the joint venture is included in the notes to our consolidated financial statements in our Annual Report on Form 10-K for the fiscal year ended October 31, 2023. Subsequent Event On August 1, 2024, subsequent to fiscal quarter ended July 31, 2024, CooperSurgical completed the acquisition of obp Surgical, a U.S.-based medical device company with a suite of single-use cordless surgical retractors with integrated light source and evacuation channels. The purchase price of the acquisition was approximately $100.0 million, paid on August 1, 2024. The Company is in the process of finalizing purchase accounting information.

General (Policies)	9 Months Ended
General (Policies)	Jul. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Estimates	Estimates The preparation of Consolidated Condensed Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of net sales and expenses during the reporting period. Actual results could differ from those estimates. The Company continually monitors and evaluates the estimates used as additional information becomes available. Adjustments will be made to these provisions periodically to reflect new facts and circumstances that may indicate that historical experience may not be indicative of current and/or future results.
Accounting Pronouncements Issued But Not Yet Adopted	Accounting Pronouncements Issued But Not Yet Adopted In December 2023, the Financial Accounting Standards Board (FASB) issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This ASU requires public entities to disclose specific categories in the effective tax rate reconciliation and additional information for reconciling items that exceed a quantitative threshold. The guidance also requires all disaggregated information pertaining to taxes paid, net of refunds received, for federal, state and foreign income taxes. The new guidance is effective for fiscal years beginning after December 15, 2024, with the option to apply prospectively or retrospectively. Early adoption is permitted. We are currently evaluating the impact that the adoption of this guidance will have on our consolidated financial statements and disclosures. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which enhances the disclosures required for operating segments in our annual and interim consolidated financial statements. The ASU is effective for us beginning on November 1, 2024, and will be applied retrospectively. Early adoption is permitted. We are currently evaluating the impact of adopting this ASU on our consolidated financial statements and disclosures.
Contingencies and Commitments	The Company is involved in various lawsuits, claims and other legal matters from time to time that arise in the ordinary course of conducting business, including matters involving our products, intellectual property, supplier relationships, distributors, competitor relationships, employees and other matters. The Company does not believe that the ultimate resolution of these proceedings or claims pending against it could have a material adverse effect on its financial condition or results of operations. At each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450, Contingencies. Legal fees are expensed as incurred.

Stockholders' Equity (Tables)

9 Months Ended

Jul. 31, 2024

Stockholders' Equity Note [Abstract]

Schedule of changes in accumulated other comprehensive income

Analysis of Changes in Accumulated Other Comprehensive Loss:


(In millions)	Foreign Currency Translation Adjustment		Minimum Pension Liability		Derivative Instruments		Total
Balance at October 31, 2022	$	(555.0)	$	(6.2)	$	94.4	$	(466.8)
Gross change in value	103.9		—		(15.7)		88.2
Tax effect	—		—		3.8		3.8
Balance at July 31, 2023	$	(451.1)	$	(6.2)	$	82.5	$	(374.8)

Balance at October 31, 2023	$	(538.0)	$	(3.2)	$	87.4	$	(453.8)
Gross change in value	62.5		—		(44.4)		18.1
Tax effect	—		—		10.6		10.6
Balance at July 31, 2024	$	(475.5)	$	(3.2)	$	53.6	$	(425.1)

The following table details the changes in the cumulative pre-tax impact of the gain on derivatives designated for hedge accounting:


Periods Ended July 31,	Three Months				Nine Months
(In millions)	2024		2023		2024		2023
Beginning balance gain	$	106.4	$	89.5	$	115.1	$	124.5
Amount recognized in accumulated other comprehensive income on interest rate swap contracts, gross	(21.6)		31.4		(3.1)		14.6
Amount reclassified from accumulated other comprehensive income into earnings, gross	(14.1)		(12.1)		(41.3)		(30.3)
Ending balance gain	$	70.7	$	108.8	$	70.7	$	108.8

Stockholders' Equity - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) Income (Details) - USD ($)
$ in Millions

9 Months Ended

Jul. 31, 2024

Jul. 31, 2023

AOCI Attributable to Parent, Net of Tax [Roll Forward]

Stockholders' equity, beginning balance

$ 7,551.0

^[1]

$ 7,174.7

^[2]

Gross change in value

18.1

88.2

Tax effect

10.6

3.8

Stockholders' equity, ending balance

7,925.2

^[1]

7,528.5

^[2]

Accumulated Other Comprehensive Loss

AOCI Attributable to Parent, Net of Tax [Roll Forward]

Stockholders' equity, beginning balance

^[2]

(453.8)

(466.8)

Stockholders' equity, ending balance

^[2]

(425.1)

(374.8)

Foreign Currency Translation Adjustment

AOCI Attributable to Parent, Net of Tax [Roll Forward]

Stockholders' equity, beginning balance

(538.0)

(555.0)

Gross change in value

62.5

103.9

Tax effect

0.0

Stockholders' equity, ending balance

(475.5)

(451.1)

Minimum Pension Liability

AOCI Attributable to Parent, Net of Tax [Roll Forward]

Stockholders' equity, beginning balance

(3.2)

(6.2)

Gross change in value

0.0

Tax effect

0.0

Stockholders' equity, ending balance

(3.2)

(6.2)

Derivative Instruments

AOCI Attributable to Parent, Net of Tax [Roll Forward]

Stockholders' equity, beginning balance

87.4

94.4

Gross change in value

(44.4)

(15.7)

Tax effect

10.6

3.8

Stockholders' equity, ending balance

$ 53.6

$ 82.5

[1]	All periods presented have been adjusted to reflect the four-for-one stock split effected on February 16, 2024. Refer to Note 1. General for further information.
[2]	All periods presented have been adjusted to reflect the four-for-one stock split effected on February 16, 2024. Refer to Note 1. General for further information.

- Definition

Amount before tax, after reclassification adjustments of other comprehensive income (loss).

+ References + Details

- Definition

Amount of tax expense (benefit) allocated to other comprehensive income (loss).

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 12
-SubTopic 10
-Topic 220
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482790/220-10-45-12

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482765/220-10-50-4

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481674/830-30-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 17
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481694/830-30-45-17

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 20
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481694/830-30-45-20

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-10

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 20
-Name Accounting Standards Codification
-Section 45
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482659/740-20-45-11

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 20
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482659/740-20-45-2

+ Details

- Definition

Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-6

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (d)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 848
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (a)(3)(iii)(03)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483550/848-10-65-2

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 842
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 8
-Subparagraph (c)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479832/842-10-65-8

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 24
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483421/250-10-45-24

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 23
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483421/250-10-45-23

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 5
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483421/250-10-45-5

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 326
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 5
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479654/326-10-65-5

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 6
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480528/815-20-65-6

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 6
-Subparagraph (h)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480528/815-20-65-6

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 6
-Subparagraph (h)(1)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480528/815-20-65-6

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 6
-Subparagraph (h)(1)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480528/815-20-65-6

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 6
-Subparagraph (h)(1)(iv)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480528/815-20-65-6

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 6
-Subparagraph (i)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480528/815-20-65-6

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 105
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 6
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479343/105-10-65-6

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 105
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 6
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479343/105-10-65-6

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (f)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480016/944-40-65-2

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (f)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480016/944-40-65-2

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 8
-Subparagraph (d)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482615/740-10-65-8

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 8
-Subparagraph (d)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482615/740-10-65-8

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 326
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479654/326-10-65-4

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (e)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-7

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482765/220-10-50-5

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481674/830-30-50-1

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 17
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481694/830-30-45-17

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 20
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481694/830-30-45-20

Reference 34: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 11
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479168/946-830-55-11

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 205
-Name Accounting Standards Codification
-Section 45
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478009/946-205-45-3

Reference 36: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 505
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478448/946-505-50-3

Reference 37: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(19))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1

Reference 38: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.6-05(4))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2

Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(4)(b))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

Reference 40: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(6))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

Reference 41: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(7))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

Reference 42: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1

Reference 43: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 44: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481687/323-10-50-3

Reference 45: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-28

Reference 46: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481231/810-10-45-15

Reference 47: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 16
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481231/810-10-45-16

Reference 48: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4I
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481175/810-10-55-4I

Reference 49: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476166/350-60-65-1

+ Details

Inventories (Details) - USD ($) $ in Millions	Jul. 31, 2024	Oct. 31, 2023
Inventory Disclosure [Abstract]
Raw materials	$ 214.6	$ 207.3
Work-in-process	19.5	19.0
Finished goods	545.2	509.3
Total inventories	$ 779.3	$ 735.6

Financing Arrangements - Total Debt (Details) - USD ($) $ in Millions	Jul. 31, 2024	Oct. 31, 2023
Short-term Debt
Short-term debt	$ 39.8	$ 44.4
Financing lease liabilities	$ 1.0	1.0
Finance lease liabilities, short-term, location	Short-term debt
Short-term debt	$ 40.8	45.4
Long-term Debt
Less: unamortized debt issuance cost	(1.6)	(2.4)
Long-term debt, excluding financing leases	2,588.8	2,520.4
Financing lease liabilities	$ 2.8	3.4
Finance lease liabilities, long-term, location	Long-term debt
Long-term debt	$ 2,591.6	2,523.8
Total debt	2,632.4	2,569.2
Term loans
Long-term Debt
Long-term debt, gross	1,500.0	2,350.0
Other
Long-term Debt
Long-term debt, gross	0.2	0.2
Revolving Credit Facility \| Line of Credit
Long-term Debt
Long-term debt, gross	$ 1,090.2	$ 172.6

Business Segment Information - Schedule of Net Sales to Unaffiliated Customers by Country of Domicile (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]
Total net sales	$ 1,002.8	$ 930.2	$ 2,877.0	$ 2,666.1
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Total net sales	511.2	462.5	1,460.6	1,340.4
Europe
Revenues from External Customers and Long-Lived Assets [Line Items]
Total net sales	297.0	279.7	850.3	777.4
Rest of world
Revenues from External Customers and Long-Lived Assets [Line Items]
Total net sales	$ 194.6	$ 188.0	$ 566.1	$ 548.3

- Definition

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 924
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-42

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-40

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-4

+ Details

Financing Arrangements

9 Months Ended

Jul. 31, 2024

Debt Disclosure [Abstract]

Financing Arrangements

Note 5. Financing Arrangements

The Company had outstanding debt as follows:


(In millions)	July 31, 2024		October 31, 2023
Short-term debt, excluding financing leases	$	39.8	$	44.4
Financing lease liabilities	1.0		1.0
Short-term debt	$	40.8	$	45.4

Revolving credit	$	1,090.2	$	172.6
Term loans	1,500.0		2,350.0
Other	0.2		0.2
Less: unamortized debt issuance cost	(1.6)		(2.4)
Long-term debt, excluding financing leases	2,588.8		2,520.4
Financing lease liabilities	2.8		3.4
Long-term debt	$	2,591.6	$	2,523.8
Total debt	$	2,632.4	$	2,569.2

Additional information regarding our indebtedness is included in our notes to our consolidated financial statements in our Annual Report on Form 10-K for the fiscal year ended October 31, 2023. The carrying value of the Company's revolving credit facility and term loans approximates fair value based on current market rates (Level 2). As of July 31, 2024, the Company was in compliance with all debt covenants.

Revolving Credit Agreement on May 1, 2024

On May 1, 2024, the Company entered into a Revolving Credit Agreement (the 2024 Credit Agreement), among the Company, CooperVision International Limited, the lenders from time to time party thereto, and PNC Bank, National Association, as administrative agent. The 2024 Credit Agreement provides for a multicurrency revolving credit facility (the 2024 Revolving Credit Facility) in an aggregate principal amount of $2.3 billion which, unless terminated earlier, matures on May 1, 2029. On May 1, 2024, the Company used $1,170 million under the 2024 Revolving Credit Facility to fully repay all borrowings outstanding under the 2020 Term Loan Facility and the 2020 Revolving Credit Facility, and terminated the 2020 Credit Agreement. The Company has an uncommitted option to increase the revolving credit facility or establish a new term loan in an aggregate amount up to the greater of $1,150 million or 100% of consolidated Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA), as defined in the 2024 Credit Agreement.

The 2024 Credit Agreement will bear interest, at the Company’s option, at either the base rate, or the adjusted SOFR, or adjusted foreign currency rate, plus, in each case, an applicable rate of between 0.00% and 0.50% in respect of base rate loans, and between 0.87% and 1.50% in respect of adjusted SOFR or adjusted foreign currency rate loans, in each case in accordance with a pricing grid tied to the Total Leverage Ratio, as defined in the 2024 Credit Agreement.

The Company pays an annual commitment fee that ranges from 0.10% to 0.20% of the unused portion of the 2024 Revolving Credit Facility based upon the Company’s Total Leverage Ratio, as defined in the 2024 Credit Agreement.

The 2024 Credit Agreement contains customary restrictive covenants, as well as financial covenants that require the Company to maintain a certain Total Leverage Ratio and Interest Coverage Ratio, each as defined in the 2024 Credit Agreement, consistent with the 2020 Credit Agreement discussed above.

On July 31, 2024, the Company had $1.1 billion outstanding under the 2024 Revolving Credit Facility and the weighted-average interest rate on the 2024 Revolving Credit Facility was 6.57%.

Term Loan Agreement on December 17, 2021

On December 17, 2021, the Company entered into a Term Loan Agreement (the 2021 Credit Agreement) by and among the Company, the lenders from time to time party thereto, and PNC Bank, National Association, as administrative agent. The 2021 Credit Agreement provides for a term loan facility (the 2021 Term Loan Facility) in an aggregate principal amount of $1.5 billion, which, unless terminated earlier, matures on December 17, 2026.

On May 1, 2024, in connection with the Company's entry into the 2024 Credit Agreement, the Company entered into Amendment No. 2 to the 2021 Credit Agreement, modifying the 2021 Credit Agreement by, among other things, conforming certain provisions therein to those contained in the 2024 Credit Agreement.

On July 31, 2024, the Company had $1.5 billion outstanding under the 2021 Term Loan Facility and the interest rate was 6.44%.

Revolving Credit and Term Loan Agreement on April 1, 2020

On April 1, 2020, the Company entered into a Revolving Credit and Term Loan Agreement (the 2020 Credit Agreement), among the Company, CooperVision International Holding Company, LP, CooperSurgical Netherlands B.V., CooperVision Holding Kft, the lenders from time to time party thereto, and KeyBank National Association, as administrative agent. The 2020 Credit Agreement provides for (a) a multicurrency revolving credit facility (the 2020 Revolving Credit Facility) in an aggregate principal amount of $1,290 million and (b) a term loan facility (the 2020 Term Loan Facility) in an aggregate principal amount of $850.0 million, each of which, unless terminated earlier, mature on April 1, 2025. The Company has an uncommitted option to increase the revolving credit facility or establish a new term loan in an aggregate amount up to $1,605 million.

On May 1, 2024, in connection with the Company's entry into the 2024 Credit Agreement, the Company terminated the 2020 Credit Agreement. In connection with the termination, all borrowings outstanding under the 2020 Credit Agreement were repaid.

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481544/470-10-50-6

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481544/470-10-50-6

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 470
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/470/tableOfContent

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482925/835-30-45-2

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

+ Details

Consolidated Condensed Statements of Stockholders' Equity - USD ($)
shares in Millions, $ in Millions

Total

Common Shares

Treasury Stock

Additional Paid-In Capital

Accumulated Other Comprehensive Loss

Retained Earnings

Noncontrolling Interests

Common stock, beginning balance (in shares) at Oct. 31, 2022

^[1]

197.4

Stockholders' equity, beginning balance at Oct. 31, 2022

^[1]

$ 7,174.7

$ 19.7

$ (714.5)

$ 1.8

$ 1,749.4

$ (466.8)

$ 6,584.9

$ 0.2

Treasury stock, beginning balance (in shares) at Oct. 31, 2022

^[1]

17.8

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income

84.6

Other comprehensive income (loss), net of tax

63.0

Issuance of common stock for stock plans, net and employee stock purchase plan (in shares)

0.4

1.2

Issuance of common stock for stock plans, net and employee stock purchase plan

(1.3)

(2.5)

Dividends on common stock ($0.01 per share)

(1.5)

Share-based compensation expense

16.2

Common stock, ending balance (in shares) at Jan. 31, 2023

^[1]

197.8

Stockholders' equity, ending balance at Jan. 31, 2023

^[1]

7,335.7

$ 19.7

$ (713.3)

1.8

1,763.1

(403.8)

6,668.0

0.2

Treasury stock, ending balance (in shares) at Jan. 31, 2023

^[1]

17.8

Common stock, beginning balance (in shares) at Oct. 31, 2022

^[1]

197.4

Stockholders' equity, beginning balance at Oct. 31, 2022

^[1]

7,174.7

$ 19.7

$ (714.5)

1.8

1,749.4

(466.8)

6,584.9

0.2

Treasury stock, beginning balance (in shares) at Oct. 31, 2022

^[1]

17.8

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income

209.7

Common stock, ending balance (in shares) at Jul. 31, 2023

^[1]

198.1

Stockholders' equity, ending balance at Jul. 31, 2023

^[1]

7,528.5

$ 19.8

$ (711.3)

1.8

1,801.2

(374.8)

6,791.6

0.2

Treasury stock, ending balance (in shares) at Jul. 31, 2023

^[1]

17.7

Common stock, beginning balance (in shares) at Jan. 31, 2023

^[1]

197.8

Stockholders' equity, beginning balance at Jan. 31, 2023

^[1]

7,335.7

$ 19.7

$ (713.3)

1.8

1,763.1

(403.8)

6,668.0

0.2

Treasury stock, beginning balance (in shares) at Jan. 31, 2023

^[1]

17.8

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income

39.8

Other comprehensive income (loss), net of tax

(20.0)

Issuance of common stock for stock plans, net and employee stock purchase plan (in shares)

0.2

Issuance of common stock for stock plans, net and employee stock purchase plan

7.8

$ 0.1

$ 1.0

6.7

Share-based compensation expense

14.7

Common stock, ending balance (in shares) at Apr. 30, 2023

^[1]

198.0

Stockholders' equity, ending balance at Apr. 30, 2023

^[1]

7,378.0

$ 19.8

$ (712.3)

1.8

1,784.5

(423.8)

6,707.8

0.2

Treasury stock, ending balance (in shares) at Apr. 30, 2023

^[1]

17.8

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income

85.3

Other comprehensive income (loss), net of tax

49.0

Issuance of common stock for stock plans, net and employee stock purchase plan (in shares)

0.1

(0.1)

Issuance of common stock for stock plans, net and employee stock purchase plan

2.5

$ 1.0

1.5

Dividends on common stock ($0.01 per share)

(1.5)

Share-based compensation expense

15.2

Common stock, ending balance (in shares) at Jul. 31, 2023

^[1]

198.1

Stockholders' equity, ending balance at Jul. 31, 2023

^[1]

$ 7,528.5

$ 19.8

$ (711.3)

1.8

1,801.2

(374.8)

6,791.6

0.2

Treasury stock, ending balance (in shares) at Jul. 31, 2023

^[1]

17.7

Common stock, beginning balance (in shares) at Oct. 31, 2023

198.1

^[2]

198.1

^[1]

Stockholders' equity, beginning balance at Oct. 31, 2023

$ 7,551.0

^[2]

$ 19.8

^[1]

$ (710.3)

^[1]

1.8

^[1]

1,817.2

^[1]

(453.8)

^[1]

6,876.1

^[1]

0.2

^[1]

Treasury stock, beginning balance (in shares) at Oct. 31, 2023

17.7

^[2]

17.7

^[1]

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income

$ 81.2

81.2

Other comprehensive income (loss), net of tax

31.8

Issuance of common stock for stock plans, net and employee stock purchase plan (in shares)

0.6

Issuance of common stock for stock plans, net and employee stock purchase plan

7.7

$ 1.1

6.6

Share-based compensation expense

23.6

Common stock, ending balance (in shares) at Jan. 31, 2024

^[1]

198.7

Stockholders' equity, ending balance at Jan. 31, 2024

^[1]

$ 7,695.3

$ 19.8

$ (709.2)

1.8

1,847.4

(422.0)

6,957.3

0.2

Treasury stock, ending balance (in shares) at Jan. 31, 2024

^[1]

17.7

Common stock, beginning balance (in shares) at Oct. 31, 2023

198.1

^[2]

198.1

^[1]

Stockholders' equity, beginning balance at Oct. 31, 2023

$ 7,551.0

^[2]

$ 19.8

^[1]

$ (710.3)

^[1]

1.8

^[1]

1,817.2

^[1]

(453.8)

^[1]

6,876.1

^[1]

0.2

^[1]

Treasury stock, beginning balance (in shares) at Oct. 31, 2023

17.7

^[2]

17.7

^[1]

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income

$ 274.8

Common stock, ending balance (in shares) at Jul. 31, 2024

199.1

^[2]

199.1

^[1]

Stockholders' equity, ending balance at Jul. 31, 2024

$ 7,925.2

^[2]

$ 19.9

^[1]

$ (707.2)

^[1]

1.8

^[1]

1,884.7

^[1]

(425.1)

^[1]

7,150.9

^[1]

0.2

^[1]

Treasury stock, ending balance (in shares) at Jul. 31, 2024

17.6

^[2]

17.6

^[1]

Common stock, beginning balance (in shares) at Jan. 31, 2024

^[1]

198.7

Stockholders' equity, beginning balance at Jan. 31, 2024

^[1]

$ 7,695.3

$ 19.8

$ (709.2)

1.8

1,847.4

(422.0)

6,957.3

0.2

Treasury stock, beginning balance (in shares) at Jan. 31, 2024

^[1]

17.7

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income

88.9

Other comprehensive income (loss), net of tax

(0.6)

Issuance of common stock for stock plans, net and employee stock purchase plan (in shares)

0.4

Issuance of common stock for stock plans, net and employee stock purchase plan

3.5

$ 0.1

$ 0.9

2.5

Share-based compensation expense

16.8

Common stock, ending balance (in shares) at Apr. 30, 2024

^[1]

199.1

Stockholders' equity, ending balance at Apr. 30, 2024

^[1]

7,803.9

$ 19.9

$ (708.3)

1.8

1,866.7

(422.6)

7,046.2

0.2

Treasury stock, ending balance (in shares) at Apr. 30, 2024

^[1]

17.7

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income

104.7

Other comprehensive income (loss), net of tax

(2.5)

Issuance of common stock for stock plans, net and employee stock purchase plan (in shares)

(0.1)

Issuance of common stock for stock plans, net and employee stock purchase plan

2.0

$ 1.1

0.9

Share-based compensation expense

$ 17.1

17.1

Common stock, ending balance (in shares) at Jul. 31, 2024

199.1

^[2]

199.1

^[1]

Stockholders' equity, ending balance at Jul. 31, 2024

$ 7,925.2

^[2]

$ 19.9

^[1]

$ (707.2)

^[1]

$ 1.8

^[1]

$ 1,884.7

^[1]

$ (425.1)

^[1]

$ 7,150.9

^[1]

$ 0.2

^[1]

Treasury stock, ending balance (in shares) at Jul. 31, 2024

17.6

^[2]

17.6

^[1]

[1]	All periods presented have been adjusted to reflect the four-for-one stock split effected on February 16, 2024. Refer to Note 1. General for further information.
[2]	All periods presented have been adjusted to reflect the four-for-one stock split effected on February 16, 2024. Refer to Note 1. General for further information.

Intangible Assets - Summary Of Intangible Assets (Details) - USD ($) $ in Millions	Jul. 31, 2024	Oct. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 3,136.7	$ 2,916.1
Accumulated Amortization	1,351.8	1,215.1
Intangible assets with definite lives, net	$ 1,784.9	1,701.0
Weighted-Average Amortization Period (in years)	16 years
Intangible assets with indefinite lives, net	$ 1.9	9.3
Total other intangibles, net	1,786.8	1,710.3
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	1,123.0	1,099.2
Accumulated Amortization	$ 387.6	345.8
Weighted-Average Amortization Period (in years)	19 years
Composite intangible assets
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 1,101.5	1,061.9
Accumulated Amortization	$ 477.9	424.8
Weighted-Average Amortization Period (in years)	15 years
Technology
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 660.0	494.5
Accumulated Amortization	$ 372.7	335.4
Weighted-Average Amortization Period (in years)	12 years
Trademarks
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 204.2	208.9
Accumulated Amortization	$ 87.1	81.1
Weighted-Average Amortization Period (in years)	15 years
License and distribution rights and other
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 48.0	51.6
Accumulated Amortization	$ 26.5	$ 28.0
Weighted-Average Amortization Period (in years)	11 years

Financing Arrangements (Tables)

9 Months Ended

Jul. 31, 2024

Debt Disclosure [Abstract]

Schedule of debt

The Company had outstanding debt as follows:


(In millions)	July 31, 2024		October 31, 2023
Short-term debt, excluding financing leases	$	39.8	$	44.4
Financing lease liabilities	1.0		1.0
Short-term debt	$	40.8	$	45.4

Revolving credit	$	1,090.2	$	172.6
Term loans	1,500.0		2,350.0
Other	0.2		0.2
Less: unamortized debt issuance cost	(1.6)		(2.4)
Long-term debt, excluding financing leases	2,588.8		2,520.4
Financing lease liabilities	2.8		3.4
Long-term debt	$	2,591.6	$	2,523.8
Total debt	$	2,632.4	$	2,569.2

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Jul. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Business Segment Information

9 Months Ended

Jul. 31, 2024

Segment Reporting [Abstract]

Business Segment Information

Note 11. Business Segment Information

The following tables present revenue and other financial information by reportable segment:

Segment information:


Periods Ended July 31,	Three Months				Nine Months
(In millions)	2024		2023		2024		2023
CooperVision net sales by category:
Toric and multifocal	$	326.4	$	296.5	$	934.0	$	838.5
Sphere, other	349.2		333.7		999.0		962.3


Total CooperVision net sales	$	675.6	$	630.2	$	1,933.0	$	1,800.8
CooperSurgical net sales by category:
Office and surgical	$	197.9	$	178.4	$	571.9	$	506.6
Fertility	129.3		121.6		372.1		358.7
Total CooperSurgical net sales	327.2		300.0		944.0		865.3
Total net sales	$	1,002.8	$	930.2	$	2,877.0	$	2,666.1
Operating income (loss):
CooperVision	$	172.7	$	151.7	$	487.7	$	449.7
CooperSurgical	41.3		18.8		86.9		0.3
Corporate	(21.5)		(18.9)		(67.3)		(52.6)
Total operating income	192.5		151.6		507.3		397.4
Interest expense	28.5		26.8		87.3		79.0


Other expense, net	0.3		6.0		6.3		11.9
Income before income taxes	$	163.7	$	118.8	$	413.7	$	306.5


(In millions)	July 31, 2024		October 31, 2023
Total identifiable assets:
CooperVision	$	7,172.0	$	7,044.0
CooperSurgical	4,716.8		4,351.8
Corporate	219.2		263.1
Total	$	12,108.0	$	11,658.9

Geographic information:


Periods Ended July 31,	Three Months				Nine Months
(In millions)	2024		2023		2024		2023
Net sales to unaffiliated customers by country of domicile:
United States	$	511.2	$	462.5	$	1,460.6	$	1,340.4
Europe	297.0		279.7		850.3		777.4
Rest of world	194.6		188.0		566.1		548.3
Total	$	1,002.8	$	930.2	$	2,877.0	$	2,666.1


(In millions)	July 31, 2024		October 31, 2023
Net property, plant and equipment by country of domicile:
United States	$	1,094.1	$	1,027.6
Europe	377.9		325.9
Rest of world	275.6		279.1
Total	$	1,747.6	$	1,632.6

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 48
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-48

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-31

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 34
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-34

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-15

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-42

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-40

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/280/tableOfContent

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-21

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-21

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

+ Details

Inventories

9 Months Ended

Jul. 31, 2024

Inventory Disclosure [Abstract]

Inventories

Note 3. Inventories


(In millions)	July 31, 2024		October 31, 2023
Raw materials	$	214.6	$	207.3
Work-in-process	19.5		19.0
Finished goods	545.2		509.3
Total inventories	$	779.3	$	735.6

Earnings Per Share (Tables)

9 Months Ended

Jul. 31, 2024

Earnings Per Share [Abstract]

Schedule of earnings per share


Periods Ended July 31,	Three Months				Nine Months
(In millions, except per share amounts)	2024		2023		2024		2023
Net income	$	104.7	$	85.3	$	274.8	$	209.7
Basic:
Weighted-average common shares	199.1		198.1		198.8		197.8
Basic earnings per share	$	0.53	$	0.43	$	1.38	$	1.06
Diluted:
Weighted-average common shares	199.1		198.1		198.8		197.8
Effect of dilutive stock plans	1.5		1.5		1.5		1.4
Diluted weighted-average common shares	200.6		199.6		200.3		199.2
Diluted earnings per share	$	0.52	$	0.43	$	1.37	$	1.05

Schedule of stock options and restricted stock units that were not included in the diluted earnings per share calculation

The following table sets forth stock options to purchase our common stock and restricted stock units that were not included in the diluted earnings per share calculation because their effect would have been antidilutive for the periods presented:


Periods Ended July 31,	Three Months		Nine Months
(In thousands, except exercise prices)	2024	2023	2024	2023
Stock option shares excluded	828	820	828	1,244
Exercise prices	$82.46 - $101.54	$82.46 - $101.54	$82.46 - $101.54	$75.03 - $101.54
Restricted stock units excluded	5	8	2	64

Share-Based Compensation (Tables)

9 Months Ended

Jul. 31, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of compensation expense and related income tax benefit for share-based awards

The compensation expense and related income tax benefit recognized in our Consolidated Condensed Statements of Income and Comprehensive Income for share-based awards, including the Employee Stock Purchase Plan, were as follows:


Periods Ended July 31,	Three Months				Nine Months
(In millions)	2024		2023		2024		2023
Selling, general and administrative expense	$	15.8	$	13.7	$	53.0	$	41.5
Cost of sales	1.3		1.1		3.6		3.1
Research and development expense	0.5		0.7		2.1		2.3
Total share-based compensation expense	$	17.6	$	15.5	$	58.7	$	46.9
Related income tax benefit	$	1.0	$	1.3	$	5.8	$	4.6

Consolidated Condensed Statements of Income and Comprehensive Income (Parenthetical)	Feb. 16, 2024
Income Statement [Abstract]
Stock split, conversion ratio	4

Earnings Per Share - Schedule of Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions

3 Months Ended

9 Months Ended

Jul. 31, 2024

Apr. 30, 2024

Jan. 31, 2024

Jul. 31, 2023

Apr. 30, 2023

Jan. 31, 2023

Jul. 31, 2024

Jul. 31, 2023

Earnings Per Share [Abstract]

Net income

$ 104.7

$ 88.9

$ 81.2

$ 85.3

$ 39.8

$ 84.6

$ 274.8

$ 209.7

Basic:

Weighted-average common shares (in shares)

^[1]

199.1

198.1

198.8

197.8

Basic earnings per share (in dollars per share)

^[1]

$ 0.53

$ 0.43

$ 1.38

$ 1.06

Diluted:

Weighted-average common shares (in shares)

^[1]

199.1

198.1

198.8

197.8

Effect of dilutive stock plans (in shares)

1.5

1.4

Diluted weighted average common shares (in shares)

^[1]

200.6

199.6

200.3

199.2

Diluted earnings per share (in dollars per share)

^[1]

$ 0.52

$ 0.43

$ 1.37

$ 1.05

[1]	All periods presented have been adjusted to reflect the four-for-one stock split effected on February 16, 2024. Refer to Note 1. General for further information.

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References

+ Details

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

+ Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-6

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-9

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481687/323-10-50-3

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-28

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482765/220-10-50-6

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-3

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-8

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-4

Reference 17: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479168/946-830-55-10

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479105/946-220-45-7

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(9))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(1)(d))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-7

Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-28

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A

Reference 36: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B

Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

+ Details

Business Segment Information - Schedule of Segment Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Segment Reporting Information [Line Items]
Total net sales	$ 1,002.8	$ 930.2	$ 2,877.0	$ 2,666.1
Total operating income	192.5	151.6	507.3	397.4
Interest expense	28.5	26.8	87.3	79.0
Other expense, net	0.3	6.0	6.3	11.9
Income before income taxes	163.7	118.8	413.7	306.5
Operating Segments \| CooperVision
Segment Reporting Information [Line Items]
Total net sales	675.6	630.2	1,933.0	1,800.8
Total operating income	172.7	151.7	487.7	449.7
Operating Segments \| CooperSurgical
Segment Reporting Information [Line Items]
Total net sales	327.2	300.0	944.0	865.3
Total operating income	41.3	18.8	86.9	0.3
Operating Segments \| Toric and multifocal \| CooperVision
Segment Reporting Information [Line Items]
Total net sales	326.4	296.5	934.0	838.5
Operating Segments \| Sphere, other \| CooperVision
Segment Reporting Information [Line Items]
Total net sales	349.2	333.7	999.0	962.3
Operating Segments \| Office and surgical \| CooperSurgical
Segment Reporting Information [Line Items]
Total net sales	197.9	178.4	571.9	506.6
Operating Segments \| Fertility \| CooperSurgical
Segment Reporting Information [Line Items]
Total net sales	129.3	121.6	372.1	358.7
Corporate
Segment Reporting Information [Line Items]
Total operating income	$ (21.5)	$ (18.9)	$ (67.3)	$ (52.6)

Financial Derivatives and Hedging (Tables)

9 Months Ended

Jul. 31, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of derivative instruments recognized in condensed consolidated statements of income

The following table summarizes the amounts recognized with respect to our derivative instruments within the accompanying Consolidated Condensed Statements of Income and Comprehensive Income:


Periods Ended July 31,		Three Months				Nine Months
(In millions)		2024		2023		2024		2023
Derivatives designated as cash flow hedges	Location of (Gain)/Loss Recognized on Derivatives
Interest rate swap contracts	Interest expense (income)	$	(14.1)	$	(12.1)	$	(41.3)	$	(30.3)

Schedule of changes in accumulated other comprehensive income

Analysis of Changes in Accumulated Other Comprehensive Loss:


(In millions)	Foreign Currency Translation Adjustment		Minimum Pension Liability		Derivative Instruments		Total
Balance at October 31, 2022	$	(555.0)	$	(6.2)	$	94.4	$	(466.8)
Gross change in value	103.9		—		(15.7)		88.2
Tax effect	—		—		3.8		3.8
Balance at July 31, 2023	$	(451.1)	$	(6.2)	$	82.5	$	(374.8)

Balance at October 31, 2023	$	(538.0)	$	(3.2)	$	87.4	$	(453.8)
Gross change in value	62.5		—		(44.4)		18.1
Tax effect	—		—		10.6		10.6
Balance at July 31, 2024	$	(475.5)	$	(3.2)	$	53.6	$	(425.1)

The following table details the changes in the cumulative pre-tax impact of the gain on derivatives designated for hedge accounting:


Periods Ended July 31,	Three Months				Nine Months
(In millions)	2024		2023		2024		2023
Beginning balance gain	$	106.4	$	89.5	$	115.1	$	124.5
Amount recognized in accumulated other comprehensive income on interest rate swap contracts, gross	(21.6)		31.4		(3.1)		14.6
Amount reclassified from accumulated other comprehensive income into earnings, gross	(14.1)		(12.1)		(41.3)		(30.3)
Ending balance gain	$	70.7	$	108.8	$	70.7	$	108.8

Intangible Assets - Remaining Amortization Expenses for Intangible Assets with Definite Lives (Details) - USD ($) $ in Millions	Jul. 31, 2024	Oct. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2024	$ 48.6
2025	191.6
2026	184.0
2027	169.7
2028	165.2
Thereafter	1,025.8
Intangible assets with definite lives, net	$ 1,784.9	$ 1,701.0

General	9 Months Ended
General	Jul. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
General	Note 1. General The accompanying Consolidated Condensed Financial Statements of The Cooper Companies, Inc. and its subsidiaries have been prepared in accordance with generally accepted accounting principles in the United States (GAAP) for interim financial information and with the requirements of Regulation S-X, Rule 10-01 for financial statements required to be filed as a part of this Quarterly Report on Form 10-Q. Unless the context requires otherwise, terms "the Company", "we", "us", and "our" are used to refer collectively to The Cooper Companies, Inc. and its subsidiaries. The accompanying Consolidated Condensed Financial Statements and related notes are unaudited and should be read in conjunction with the audited Consolidated Financial Statements of the Company and related notes as contained in the Company’s Annual Report on Form 10-K for the fiscal year ended October 31, 2023. The Consolidated Condensed Financial Statements include all adjustments (consisting only of normal recurring adjustments) and accruals necessary in the judgment of management for a fair presentation of the results for the interim periods presented. Accounting Policies There have been no material changes to our significant accounting policies1 described in our Annual Report on Form 10-K for the fiscal year ended October 31, 2023. Estimates The preparation of Consolidated Condensed Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of net sales and expenses during the reporting period. Actual results could differ from those estimates. The Company continually monitors and evaluates the estimates used as additional information becomes available. Adjustments will be made to these provisions periodically to reflect new facts and circumstances that may indicate that historical experience may not be indicative of current and/or future results. Stock Split On February 16, 2024, the Company effected a four-for-one stock split of its outstanding shares of common stock. The par value of the common stock remains at $0.10 per share. Accordingly, an amount equal to the par value of the increased shares resulting from the stock split was reclassified from "Additional paid-in capital" to "Common stock". All share and per share information has been retroactively adjusted to reflect the stock split for all periods presented. Accounting Pronouncements Issued But Not Yet Adopted In December 2023, the Financial Accounting Standards Board (FASB) issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This ASU requires public entities to disclose specific categories in the effective tax rate reconciliation and additional information for reconciling items that exceed a quantitative threshold. The guidance also requires all disaggregated information pertaining to taxes paid, net of refunds received, for federal, state and foreign income taxes. The new guidance is effective for fiscal years beginning after December 15, 2024, with the option to apply prospectively or retrospectively. Early adoption is permitted. We are currently evaluating the impact that the adoption of this guidance will have on our consolidated financial statements and disclosures. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which enhances the disclosures required for operating segments in our annual and interim consolidated financial statements. The ASU is effective for us beginning on November 1, 2024, and will be applied retrospectively. Early adoption is permitted. We are currently evaluating the impact of adopting this ASU on our consolidated financial statements and disclosures.

Business Segment Information - Schedule of Net Property, Plant and Equipment By Country of Domicile (Details) - USD ($) $ in Millions	Jul. 31, 2024	Oct. 31, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]
Net property, plant and equipment	$ 1,747.6	$ 1,632.6
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Net property, plant and equipment	1,094.1	1,027.6
Europe
Revenues from External Customers and Long-Lived Assets [Line Items]
Net property, plant and equipment	377.9	325.9
Rest of world
Revenues from External Customers and Long-Lived Assets [Line Items]
Net property, plant and equipment	$ 275.6	$ 279.1

Financial Derivatives and Hedging

9 Months Ended

Jul. 31, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Financial Derivatives and Hedging

Note 12. Financial Derivatives and Hedging

As of July 31, 2024, the notional amount of outstanding foreign currency forward contracts was $58.6 million. The resulting impact on our Consolidated Financial Statements from currency hedging activities was not significant for the three and nine months ended July 31, 2024, and July 31, 2023.

As of July 31, 2024, the Company has 9 interest rate swap contracts that have a total notional amount of $1.8 billion and remaining maturities of less than four years.

The following table summarizes the amounts recognized with respect to our derivative instruments within the accompanying Consolidated Condensed Statements of Income and Comprehensive Income:


Periods Ended July 31,		Three Months				Nine Months
(In millions)		2024		2023		2024		2023
Derivatives designated as cash flow hedges	Location of (Gain)/Loss Recognized on Derivatives
Interest rate swap contracts	Interest expense (income)	$	(14.1)	$	(12.1)	$	(41.3)	$	(30.3)

The cumulative pre-tax impact of the gain on derivatives designated for hedge accounting is recognized in "Accumulated other comprehensive loss". The following table details the changes in the cumulative pre-tax impact of the gain on derivatives designated for hedge accounting:


Periods Ended July 31,	Three Months				Nine Months
(In millions)	2024		2023		2024		2023
Beginning balance gain	$	106.4	$	89.5	$	115.1	$	124.5
Amount recognized in accumulated other comprehensive income on interest rate swap contracts, gross	(21.6)		31.4		(3.1)		14.6
Amount reclassified from accumulated other comprehensive income into earnings, gross	(14.1)		(12.1)		(41.3)		(30.3)
Ending balance gain	$	70.7	$	108.8	$	70.7	$	108.8

The amount recognized in other comprehensive income on interest rate swap contracts was $(16.5) million and $(2.7) million, net of tax, for the three and nine months ended July 31, 2024, respectively, and $23.8 million and $11.1 million, net of tax, for the three and nine months ended July 31, 2023, respectively.

The amount reclassified from other comprehensive income into earnings was $(10.7) million and $(31.1) million, net of tax, for the three and nine months ended July 31, 2024, respectively, and $(9.2) million and $(23.0) million, net of tax, for the three and nine months ended July 31, 2023, respectively.

Refer to Note 9. Stockholders' Equity for amounts presented net of the related tax impact in "Accumulated other comprehensive loss."

The Company expects that $(41.8) million recorded as a component of "Accumulated other comprehensive loss" will be realized in the Consolidated Condensed Statements of Income over the next twelve months and the amount will vary depending on prevailing interest rates.

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended						9 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Millions	Jul. 31, 2024	Apr. 30, 2024	Jan. 31, 2024	Jul. 31, 2023	Apr. 30, 2023	Jan. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Pay vs Performance Disclosure
Net income	$ 104.7	$ 88.9	$ 81.2	$ 85.3	$ 39.8	$ 84.6	$ 274.8	$ 209.7

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-6

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-9

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481687/323-10-50-3

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-28

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482765/220-10-50-6

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-3

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-8

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-4

Reference 17: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479168/946-830-55-10

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479105/946-220-45-7

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(9))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(1)(d))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-7

Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-28

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A

Reference 36: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B

Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

+ Details

Share-Based Compensation

9 Months Ended

Jul. 31, 2024

Share-Based Payment Arrangement [Abstract]

Share-Based Compensation

Note 8. Share-Based Compensation

The Company has several stock plans that are described in the Company’s Annual Report on Form 10‑K for the fiscal year ended October 31, 2023. The compensation expense and related income tax benefit recognized in our Consolidated Condensed Statements of Income and Comprehensive Income for share-based awards, including the Employee Stock Purchase Plan, were as follows:


Periods Ended July 31,	Three Months				Nine Months
(In millions)	2024		2023		2024		2023
Selling, general and administrative expense	$	15.8	$	13.7	$	53.0	$	41.5
Cost of sales	1.3		1.1		3.6		3.1
Research and development expense	0.5		0.7		2.1		2.3
Total share-based compensation expense	$	17.6	$	15.5	$	58.7	$	46.9
Related income tax benefit	$	1.0	$	1.3	$	5.8	$	4.6

Consolidated Condensed Balance Sheets (Parenthetical)
$ in Millions

Jul. 31, 2024

USD ($)

$ / shares

Oct. 31, 2023

USD ($)

$ / shares

Statement of Financial Position [Abstract]

Trade accounts receivable, allowance for doubtful accounts | $

$ 42.8

$ 31.3

Preferred stock, par value (in dollars per share) | $ / shares

^[1]

$ 0.10

Preferred stock, authorized (in shares)

^[1]

1,000,000.0

Preferred stock, issued (in shares)

^[1]

Preferred stock, outstanding (in shares)

^[1]

Common stock, par value (in dollars per share) | $ / shares

^[1]

$ 0.10

Common stock, authorized (in shares)

^[1]

480,000,000.0

Common stock, issued (in shares)

^[1]

216,700,000

215,800,000

Common stock, outstanding (in shares)

^[1]

199,100,000

198,100,000

Treasury stock (in shares)

^[1]

17,600,000

17,700,000

[1]	All periods presented have been adjusted to reflect the four-for-one stock split effected on February 16, 2024. Refer to Note 1. General for further information.

Financial Derivatives and Hedging - Schedule of Changes in Accumulated Other Comprehensive Income (Details) - USD ($)
$ in Millions

3 Months Ended

9 Months Ended

Jul. 31, 2024

Jul. 31, 2023

Jul. 31, 2024

Jul. 31, 2023

AOCI Attributable To Parent, Before Reclassification And Tax [Roll Forward]

Stockholders' equity, beginning balance

$ 7,803.9

^[1]

$ 7,378.0

^[1]

$ 7,551.0

^[2]

$ 7,174.7

^[1]

Stockholders' equity, ending balance

7,925.2

^[2]

7,528.5

^[1]

7,925.2

^[2]

7,528.5

^[1]

Accumulated Gain (Loss), Net, Cash Flow Hedge, Before Tax, Parent

AOCI Attributable To Parent, Before Reclassification And Tax [Roll Forward]

Stockholders' equity, beginning balance

106.4

89.5

115.1

124.5

Stockholders' equity, ending balance

70.7

108.8

70.7

108.8

Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent

AOCI Attributable To Parent, Before Reclassification And Tax [Roll Forward]

Stockholders' equity, beginning balance

87.4

94.4

Amount recognized in accumulated other comprehensive income on interest rate swap contracts, gross

(21.6)

31.4

(3.1)

14.6

Amount reclassified from accumulated other comprehensive income into earnings, gross

(14.1)

(12.1)

(41.3)

(30.3)

Stockholders' equity, ending balance

$ 53.6

$ 82.5

$ 53.6

$ 82.5

[1]	All periods presented have been adjusted to reflect the four-for-one stock split effected on February 16, 2024. Refer to Note 1. General for further information.
[2]	All periods presented have been adjusted to reflect the four-for-one stock split effected on February 16, 2024. Refer to Note 1. General for further information.

- Definition

Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.

+ References

+ Details

Share-Based Compensation (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
Share-Based Compensation (Details) - USD ($) $ in Millions	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total share-based compensation expense	$ 17.6	$ 15.5	$ 58.7	$ 46.9
Related income tax benefit	1.0	1.3	5.8	4.6
Selling, general and administrative expense
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total share-based compensation expense	15.8	13.7	53.0	41.5
Cost of sales
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total share-based compensation expense	1.3	1.1	3.6	3.1
Research and development expense
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total share-based compensation expense	$ 0.5	$ 0.7	$ 2.1	$ 2.3

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 35
-Paragraph 1D
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 35
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480483/718-10-35-3

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(01)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(02)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(03)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(04)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(01)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(02)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(03)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iv)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(v)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Income Taxes (Details)	3 Months Ended		9 Months Ended
Income Taxes (Details)	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Income Tax Disclosure [Abstract]
Effective income tax rate	36.10%	28.20%	33.60%	31.60%

Income Taxes	9 Months Ended
Income Taxes	Jul. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Note 6. Income Taxes The effective tax rates for the three months ended July 31, 2024, and 2023, were 36.1% and 28.2%, respectively. The effective tax rates for the nine months ended July 31, 2024, and 2023, were 33.6% and 31.6%, respectively. The increases were primarily due to changes in the geographic composition of pre-tax earnings and an increase in the UK statutory tax rate from 19% to 25%.

- Definition

The entire disclosure for income tax.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 231
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482663/740-10-55-231

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 270
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477891/740-270-50-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.5.Q1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-13

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/740/tableOfContent

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-14

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-21

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 17
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-17

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482603/740-30-50-2

+ Details

Consolidated Condensed Statements of Income and Comprehensive Income - USD ($)
shares in Millions, $ in Millions

3 Months Ended

9 Months Ended

Jul. 31, 2024

Jul. 31, 2023

Jul. 31, 2024

Jul. 31, 2023

Income Statement [Abstract]

Net sales

$ 1,002.8

$ 930.2

$ 2,877.0

$ 2,666.1

Cost of sales

339.8

320.2

959.0

914.7

Gross profit

663.0

610.0

1,918.0

1,751.4

Selling, general and administrative expense

381.1

375.2

1,142.3

1,113.6

Research and development expense

39.0

36.5

117.4

100.7

Amortization of intangibles

50.4

46.7

151.0

139.7

Operating income

192.5

151.6

507.3

397.4

Interest expense

28.5

26.8

87.3

79.0

Other expense, net

0.3

6.0

6.3

11.9

Income before income taxes

163.7

118.8

413.7

306.5

Provision for income taxes (Note 6)

59.0

33.5

138.9

96.8

Net income

$ 104.7

$ 85.3

$ 274.8

$ 209.7

Earnings per share (Note 7):

Basic (in dollars per share)

^[1]

$ 0.53

$ 0.43

$ 1.38

$ 1.06

Diluted (in dollars per share)

^[1]

$ 0.52

$ 0.43

$ 1.37

$ 1.05

Number of shares used to compute earnings per share:

Basic (in shares)

^[1]

199.1

198.1

198.8

197.8

Diluted (in shares)

^[1]

200.6

199.6

200.3

199.2

Other comprehensive income, net of tax:

Cash flow hedges

$ (27.2)

$ 14.6

$ (33.8)

$ (11.9)

Foreign currency translation adjustment

24.7

34.4

62.5

103.9

Comprehensive income

$ 102.2

$ 134.3

$ 303.5

$ 301.7

[1]	All periods presented have been adjusted to reflect the four-for-one stock split effected on February 16, 2024. Refer to Note 1. General for further information.

Earnings Per Share

9 Months Ended

Jul. 31, 2024

Earnings Per Share [Abstract]

Earnings Per Share

Note 7. Earnings Per Share


Periods Ended July 31,	Three Months				Nine Months
(In millions, except per share amounts)	2024		2023		2024		2023
Net income	$	104.7	$	85.3	$	274.8	$	209.7
Basic:
Weighted-average common shares	199.1		198.1		198.8		197.8
Basic earnings per share	$	0.53	$	0.43	$	1.38	$	1.06
Diluted:
Weighted-average common shares	199.1		198.1		198.8		197.8
Effect of dilutive stock plans	1.5		1.5		1.5		1.4
Diluted weighted-average common shares	200.6		199.6		200.3		199.2
Diluted earnings per share	$	0.52	$	0.43	$	1.37	$	1.05


Periods Ended July 31,	Three Months		Nine Months
(In thousands, except exercise prices)	2024	2023	2024	2023
Stock option shares excluded	828	820	828	1,244
Exercise prices	$82.46 - $101.54	$82.46 - $101.54	$82.46 - $101.54	$75.03 - $101.54
Restricted stock units excluded	5	8	2	64

Financial Derivatives and Hedging - Narrative (Details) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 31, 2024 USD ($) interest_rate_swap_contract	Jul. 31, 2023 USD ($)	Jul. 31, 2024 USD ($) interest_rate_swap_contract	Jul. 31, 2023 USD ($)
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount recognized in other comprehensive income on interest rate swaps contracts, net of tax	$ (16.5)	$ 23.8	$ (2.7)	$ 11.1
Amount reclassified from other comprehensive income into earnings, net of tax	(10.7)	$ (9.2)	(31.1)	$ (23.0)
Derivative loss expected to be realized in earnings over the next twelve months			(41.8)
Foreign Exchange Forward
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative notional amount	58.6		58.6
Interest Rate Swap
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative notional amount	$ 1,800.0		$ 1,800.0
Number of interest rate swap contracts held \| interest_rate_swap_contract	9		9
Derivative, remaining maturity (less than)			4 years

Financial Derivatives and Hedging - Schedule of Derivative Instruments Recognized in Condensed Consolidated Statements of Income (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Interest expense (income) \| Interest Rate Swap
Derivative Instruments and Hedging Activities Disclosures [Line Items]
(Gain) loss recognized on derivatives within interest expense	$ (14.1)	$ (12.1)	$ (41.3)	$ (30.3)

Intangible Assets

9 Months Ended

Jul. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets

Note 4. Intangible Assets

Intangible assets consisted of the following:


	July 31, 2024				October 31, 2023
(In millions)	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization		Weighted-Average Amortization Period (in years)

Intangible assets with definite lives:
Customer relationships	$	1,123.0	$	387.6	$	1,099.2	$	345.8	19
Composite intangible assets (1)	1,101.5		477.9		1,061.9		424.8		15
Technology	660.0		372.7		494.5		335.4		12
Trademarks	204.2		87.1		208.9		81.1		15
License and distribution rights and other	48.0		26.5		51.6		28.0		11
	3,136.7		$	1,351.8	2,916.1		$	1,215.1	16
Less: accumulated amortization and translation	1,351.8				1,215.1
Intangible assets with definite lives, net	1,784.9				1,701.0
Intangible assets with indefinite lives, net (2)	1.9				9.3
Total other intangibles, net	$	1,786.8			$	1,710.3

(2) Intangible assets with indefinite lives include technology and trademarks.

Balances include foreign currency translation adjustments.

As of July 31, 2024, the estimate of future amortization expenses for intangible assets with definite lives is as follows:


Fiscal Years:	(In millions)
Remainder of 2024	$	48.6
2025	191.6
2026	184.0
2027	169.7
2028	165.2
Thereafter	1,025.8
Total remaining amortization for intangible assets with definite lives	$	1,784.9

The Company performed its annual impairment assessment in the third quarter of fiscal 2024 and concluded there was no material impairment of goodwill or intangible assets recorded in the nine months ended July 31, 2024. Further information regarding our annual impairment assessment is included in our notes to our consolidated financial statements in our Annual Report on Form 10-K for the fiscal year ended October 31, 2023.

Stockholders' Equity

9 Months Ended

Jul. 31, 2024

Stockholders' Equity Note [Abstract]

Stockholders' Equity

Note 9. Stockholders' Equity

Analysis of Changes in Accumulated Other Comprehensive Loss:


(In millions)	Foreign Currency Translation Adjustment		Minimum Pension Liability		Derivative Instruments		Total
Balance at October 31, 2022	$	(555.0)	$	(6.2)	$	94.4	$	(466.8)
Gross change in value	103.9		—		(15.7)		88.2
Tax effect	—		—		3.8		3.8
Balance at July 31, 2023	$	(451.1)	$	(6.2)	$	82.5	$	(374.8)

Balance at October 31, 2023	$	(538.0)	$	(3.2)	$	87.4	$	(453.8)
Gross change in value	62.5		—		(44.4)		18.1
Tax effect	—		—		10.6		10.6
Balance at July 31, 2024	$	(475.5)	$	(3.2)	$	53.6	$	(425.1)

Share Repurchases

In March 2017, the authorization under the 2012 Share Repurchase Program was increased to $1.0 billion by the Company's Board of Directors. As of July 31, 2024, $256.4 million remains authorized for repurchase.

During the three and nine months ended July 31, 2024, and 2023, there were no share repurchases.

Dividends

In December 2023, the Company's Board of Directors decided to end the declaration of the semiannual dividend.

The Company paid dividends of approximately $1.5 million during the nine months ended July 31, 2023.

- Definition

The entire disclosure for equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-14

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477968/946-235-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477968/946-235-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 505
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478448/946-505-50-6

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480237/815-40-50-6

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/505/tableOfContent

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-14

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-14

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 16
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-16

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-18

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-18

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-18

+ Details